Traditional 5-HT4 agonists may off-target inhibit the cardiac hERG potassium channel (IKr current), potentially leading to QT interval prolongation and significantly increasing the risk of Torsades de Pointes. This evidence concerns the gene HTR4 and torsades de pointes.